Could a simple amino acid shorten diabetic emergencies?

NCT ID NCT07167693

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tests whether a single infusion of arginine hydrochloride, a natural amino acid, can help people with type 2 diabetes recover faster from diabetic ketoacidosis (DKA), a serious complication. Sixty adults arriving at emergency rooms with DKA will receive either arginine or a placebo alongside standard care. The goal is to see if arginine boosts the body's own insulin production, clearing ketones more quickly and reducing the need for additional insulin.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
arginine hydrochloride
What this could lead to
If it works, this could offer a simple, safe way to shorten hospital stays and reduce insulin needs during diabetic ketoacidosis in type 2 diabetes.
What could go wrong
This is an early phase 1/2 trial with only 60 participants, so results may not apply broadly. The infusion may cause temporary side effects like flushing or nausea, and benefits are not guaranteed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES (DM) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Detroit Medical Center

    RECRUITING

    Detroit, Michigan, 48201, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.